Safety of Antibacterial and Antiprotozoal Medicinal Products

Shubnikova, E. V.; Bukatina, T. M.; Druzhinina, A. A.; Журавлева, Е. О.; Кутехова, Г. В.; Velts, N. Yu.

doi:10.30895/2312-7821-2022-10-2-196-199

Bezopasnost' i risk farmakoterapii

2022

DOI: 10.30895/2312-7821-2022-10-2-196-199

|View full text |Cite

Safety of Antibacterial and Antiprotozoal Medicinal Products

E. V. Shubnikova¹,

T. M. Bukatina²,

A. A. Druzhinina³

et al.

Abstract: The experts of the Scientific Centre for Expert Evaluation of Medicinal Products analysed administrative decisions of foreign regulatory authorities on the recalls of antibacterial and antiprotozoal medicinal products and/or the need for labelling updates due to changes in the safety profile. The analysis revealed 16 decisions containing information on the following medicines registered in Russia: ertapenem, сeftriaxone, cefazolin, аmoxicillin, сefoperazone+sulbactam, piperacillin+tazobactam, сlindamycin, teic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Control of Organic Impurities in Semisynthetic Antibiotics

Ковалева¹,

Arhipova²,

Bulova³

et al. 2022

Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo pr

View full text Add to dashboard Cite

In 2012, the European Medicines Agency (EMA) adopted a guideline, which divided all antibiotics into groups according to the manufacturing process and established acceptance criteria for organic impurities for each of the groups.The aim of the study was to justify the requirements and methodological approaches to setting the limits for organic impurities in semisynthetic antibiotics.Materials and methods: the authors analysed the requirements established by the leading world pharmacopoeias and the State Pharmacopoeia of the Russian Federation regarding the control of organic impurities in semisynthetic antibiotics, using the example of four semisynthetic antibiotics: doxycyline hyclate, clarithromycin, meropenem, and ceftriaxone. The study used the methods of comparative analysis and content analysis. Results: the study demonstrated that the organic impurity profiles of the analysed active substances and the corresponding finished medicinal products often differ significantly across the leading pharmacopoeias, either qualitatively or quantitatively. The Russian, European, and United States pharmacopoeias provide for the use of impurity reference standards in the test procedures for the determination of impurities in active substances of the semisynthetic antibiotics in question, whereas the Japanese Pharmacopoeia allows the use of non-compendial reference substances in the assessment of the chromatographic system separation power.Conclusions: the ability of a pharmacopoeial text to cover a variety of medicinal products coming to the Russian market from different countries has become a vital issue. This includes covering the impurity determination procedures, reference standards, and limits used, because general-purpose methods and limits do not always allow for correct assessment of impurity profiles in substances produced by different manufacturing processes. The current USP practice is to include various impurity control procedures in monographs on medicinal products, and the limits may also vary. This approach may be applied in the State Pharmacopoeia of the Russian Federation as well.

show abstract

Control of Organic Impurities in Semisynthetic Antibiotics

Ковалева¹,

Arhipova²,

Bulova³

et al. 2022

Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo pr

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Safety of Antibacterial and Antiprotozoal Medicinal Products

Cited by 1 publication

References 6 publications

Control of Organic Impurities in Semisynthetic Antibiotics

Control of Organic Impurities in Semisynthetic Antibiotics

Contact Info

Product

Resources

About